Introduction
============

*Vibrio vulnificus* is a Gram-negative halophilic bacterium and opportunistic human pathogen that causes primary septicemia and wound infections ([@B51], [@B52]; [@B45]). Epidemiological studies show that the incidence of *V. vulnificus* wound infection, which can result from exposure to seawater or through handling marine products, is increasing ([@B51]). This is primarily due to rising seawater temperatures caused by global warming, which are essential for the rapid proliferation of this pathogen ([@B73]; [@B52]). The wound infection can result in lethal septicemia or require surgery to prevent extensive tissue damage and remove bacteria from the infection sites. However, the mechanisms of pathogenesis in *V. vulnificus* wound infection remain to be elucidated.

To date, *in vivo* expression technology (IVET), *in vivo*-induced antigen technology (IVIAT), and signature-tagged mutagenesis (STM) have been used to identify virulence factors of *V. vulnificus* that are functionally expressed *in vivo*, focusing on primary septicemia ([@B32]; [@B35]; [@B80]). Both IVET and IVIAT comprise positive selection methods, which can identify genes whose expression is enhanced *in vivo* after excluding constitutively expressed genes ([@B43]; [@B32]; [@B35]). In contrast, STM is a negative selection method that can detect essential genes for *in vivo* proliferation and functionally deficient mutants ([@B19]; [@B80]). However, although harvesting sufficient bacterial number from hosts as an output pool is indispensable for the negative selection of mutants, *V. vulnificus* is not able to efficiently colonize and proliferate in mouse models of primary septicemia ([@B37]; [@B26]). Thus, STM had been considered not to be suitable for the identification of virulence genes of *V. vulnificus*. However, we could show that a sufficient number of bacteria required for the STM can be collected from a murine model of wound infection and that the lethal outcomes cannot be prevented if allowing sufficient proliferation by *V. vulnificus* in muscle tissue ([@B81]). In addition, recent epidemiological report and our previous report suggested that STM is an adequate method to identify essential genes for *V. vulnificus* proliferation only in a murine model of wound infection. [@B52] reported that 94% of patients with primary septicemia have one or more underlying disease(s), whereas over 80% of individuals presenting with *V. vulnificus* wound infection have no underlying diseases. This suggests that soft-tissues in wound infection constitute an environment for bacterial proliferation that is significantly different from the intestinal tract or systemic circulation affected in primary septicemia.

Virulence genes are preferentially expressed during infection. Both in primary septicemia and wound infection of *V. vulnificus*, the multifunctional-autoprocessing repeats-in-toxin (MARTX) toxin is known to be indispensable for pathogenicity and colonization ([@B9]; [@B40]; [@B23]). Toxic effects of the MARTX toxin are exerted in a cell contact-dependent manner and can kill host cells, leading to bacterial resistance against neutrophils ([@B33]). Moreover, the incubation period for *V. vulnificus* wound infection cases averages only 16 h, which is much shorter than that of primary septicemia ([@B52]). These findings encourage the hypothesis that *V. vulnificus* carries mechanisms for immune evasion, colonization, and rapid proliferation especially in wound infection. These processes would be mediated by factors that are constitutively expressed and preemptively function in early stages of infection, underlying its pathogenic ability to establish wound infection within a short time. To test this hypothesis, we applied STM to a murine model of wound infection, which was expected to resolve the problems of low-efficiencies in harvesting the pathogen from systemically infected animals, and identified the genes and functions required by *V. vulnificus* for efficient proliferation in wound infection.

Materials and Methods {#s1}
=====================

Animals
-------

We utilized five-week-old female C57BL/6 mice (Charles River Laboratories Japan, Yokohama, Japan) for the animal experiments. The mice were housed in a controlled environment with a 12:12-h light-dark cycle and were fed rat chow MF (Oriental Yeast, Tokyo, Japan) and tap water. Ambient temperature during the study was maintained at about 23°C.

Ethics Statement
----------------

All animal studies were carried out in strict accordance with the Guidelines for Animal Experimentation of the Japanese Association for Laboratory Animal Science. The animal experimentation protocol was approved by the President of Kitasato University based on the judgment of the Institutional Animal Care and Use Committee of Kitasato University (Approval No. 15--156).

Bacterial Strains
-----------------

*Vibrio vulnificus* CMCP6 is a clinical isolate from a male septicemic patient at the Chonnam National University Hospital, South Korea ([@B32]; [@B68]), and kindly provided by Dr. Joon Haeng Rhee (Chonnam National University, South Korea). The complete genome sequence of CMCP6 is available in some databases, Joint Genome Institute^[1](#fn01){ref-type="fn"}^ and Kyoto Encyclopedia of Genes and Genomes (KEGG)^[2](#fn02){ref-type="fn"}^. *Escherichia coli* BW19795 with signature-tagged mini-Tn5Km2 in pUT were used for conjugation of transposons to *V. vulnificus*. Δ*pomA* is a non-motile strain used as a control strain for the swarming assay ([@B18]). *V. vulnificus* E4 is unencapsulated strain (translucent colony morphology) and was used as a control strain for colony morphology. This strain was isolated from seafood in Florida, and kindly provided by Dr. Shinichi Miyoshi (Okayama University, Japan) ([@B27]).

STM
---

The scheme of STM is shown in Figure [1](#F1){ref-type="fig"}. The construction of a library containing 63 mutants with a transposon tagged by a unique sequence was performed as previously described ([@B80]). Briefly, *E. coli* BW19795 with signature-tagged mini-Tn5Km2 in pUT were combined with *V. vulnificus* on a nitrocellulose Hybond C membrane (GE Healthcare) for conjugation, placed onto an M9 agar plate, and incubated at 25°C ([@B15]; [@B10]; [@B59]). The bacterial suspension was plated onto Thiosulfate-Citrate-Bile Salts-Sucrose (TCBS) agar containing 100 μg/ml kanamycin and incubated overnight at 37°C for selection ([@B58]). Each signature-tagged transposon insertion mutants of *V. vulnificus* were grown in Luria-Bertani (LB) medium containing 100 mg/ml of kanamycin for 12 h at 37°C in 96 well plate separately. We checked each bacterial growth by measuring optical density at 600 nm (OD600) with a microplate reader (Sunrise/TECAN Japan, Kanagawa, Japan), and the mutants were pooled, washed with LB medium without any anti-biotics, and used as an input pool. Mice were subcutaneously inoculated with 10^6^ CFU of the input pool into right caudal thighs ([@B28]). The infected mice were carefully monitored and sacrificed by sevoflurane (Wako pure chemical industries, Osaka, Japan) inhalation 12 to 24 h post-infection when they displayed critical symptoms that are directly associated with death, such as deep hypothermia, and the output pool was collected from murine spleens (Figure [1](#F1){ref-type="fig"}). Selection of attenuated mutants by STM was performed in triplicate for each of 86 libraries.

![Scheme of STM application to a murine model of *V. vulnificus* wound infection. A result of tag-specific dot blot hybridization for the input pool and output pool following a round of STM. Orange circles indicate tags detected in the input pool but not in the output pool.](fmicb-10-00123-g001){#F1}

For tag-specific dot hybridization, 10 μM of the target DNA, comprising the signature-tagged sequence region of each transposon, was blotted onto Hybond-N+ membrane (GE Healthcare) and fixed with CL-1000 Ultraviolet Crosslinkers (UVP, Upland, CA, United States). DNA probes were amplified by polymerase chain reaction (PCR) with Dig-labeled primers: Dig 1 (5′-Dig-CAT GGT ACC CAT TCT AAC-3′) and Dig 2 (5′-Dig-TAC CTA CAA CCT CAA GCT-3′). PCR was performed in a 50-μl reaction mix containing 25 μl of 2 × PCR Buffer for KOD FX Neo, 5 μl of 2 mM dNTPs, 2 μl of primer mix (0.3 μM final concentration of each primer), 0.5 μl KOD FX Neo polymerase (0.5 unit, Toyobo, Osaka, Japan), 1 μl DNA template (about 200 ng genomic DNA), and distilled water. Thermal cycling conditions were as follows: (i) 5 min at 94°C; and (ii) 25 cycles of 15 s at 94°C, 45 s at 59°C, and 10 s at 68°C. The hybridization processes were performed in a hybridization oven (MHS-200e/eyelaco, Tokyo, Japan) ([@B80]).

The transposon inserted sequence was determined via arbitrarily primed PCR using specific primers targeting the transposon: Rev consensus2 I-out 1st (5′-CCA TGG GTA AGA TTG GTT CGA A-3′), consensus1 I-out 1st (5′-GGT ACC TAC AAC CTC AAG CT-3′), and Rev consensus1 I-out for 2nd (5′-AGC TTG GTT AGA ATG GGT ACC-3′), and random primers targeting the *V. vulnificus* genome: Arb1 (5′-GGC CAC GCG TCG ACT AGT CAN NNN NNN NNN GAT AT-3′), Arb3 (5′-GGC CAC GCG TCG ACT AGT CAN NNN NNN NNN TTC AA-3′), Arb4 (5′-GGC CAC GCG TCG ACT AGT CAN NNN NNN NNN CCA CG-3′), Arb5 (5′-GGC CAC GCG TCG ACT AGT CAN NNN NNN NNN ACT GA-3′), Arb6 (5′-GGC CAC GCG TCG ACT AGT CAN NNN NNN NNN ACG CG-3′), Arb7 (5′-GGC CAC GCG TCG ACT AGT CAN NNN NNN NNN TGG CA-3′), and Arb for 2nd (5′-GGC CAC GCG TCG ACT AGT CA-3′). Thermal cycling conditions of first round were as follows: (i) 5 min at 95°C; (ii) 6 cycles of 20 s at 95°C, 20 s at 30°C, and 2 min at 72°C; (iii) 30 cycles of 20 s at 95°C, 20 s at 45°C, and 2 min at 72°C; and (iv) 5 min at 72°C. PCR was performed in a 50-μl reaction mix containing 5 μl of 10 × PCR Buffer for Paq5000, 2 μl of 2 mM dNTPs, 2 μl of primer mix (0.5 μM final concentration of each primer), 0.5 μl Paq5000 polymerase (0.5 unit, Stratagene, CA, United States), 1 μl DNA template (about 200 ng genomic DNA), and distilled water. Thermal cycling conditions of second round were as follows: (i) 30 s at 95°C; (ii) 30 cycles of 20 s at 95°C, 30 s at 55°C, and 4 min at 68°C; and (iii) 5 min at 68°C. PCR was performed in a 50-μl reaction mix containing 5 μl of 10 × PCR Buffer for Taq DNA polymerase with ThermoPol, 5 μl of 2 mM dNTPs, 2 μl of primer mix (0.5 μM final concentration of each primer), 0.5 μl Taq DNA polymerase with ThermoPol (0.5 unit, New England Biolabs, MA, United States), 1 μl the PCR product of the first round, and distilled water. The DNA sequences of the PCR products were determined by using the Fasmac sequencing service (Atsugi, Japan) and used to search for sequence homologies in the KEGG.

Construction of a *pomA* Mutant and a *cheY* Mutant
---------------------------------------------------

To delete a 762-bp DNA fragment of *pomA*, approximately 1000 bp of each 5′ and 3′ of flanking regions of PomA encoding gene were amplified by PCR with the primers: *pomA* Up Fw (5′-GGG GTG ACG CCA AAG TAT ATG GTG AAT GCG AGC GTT TG-3′), *pomA* Up Rev (5′-TCT TAA GTT TGC TTC CCT CAT GCT ATT TTC CGA TTT ACC GC-3′), *pomA* Down Fw (5′-AAC GGG AGG AAA TAA TCA CGG GAG TAT GTG ATG GAT GAC G-3′), *pomA* Down Rev (5′-CTT AAC GGC TGA CAT GGG GAC GAG CAT TTC TGC TCA TC-3′), and *pomA* Flag Rev (5′-TTA TTT CCT CCC GTT TTA GAT TAC AAG GAT GAC GAC GAT AAG ATC GTT GAT ATC GAG GGC AC-3′). The amplified DNA were cloned into the suicide vector pYAK1, which contains the chloramphenicol resistant gene and *sacB* gene conferring sensitivity to sucrose ([@B34]).

A 2859-bp DNA fragment including *cheY* was amplified using specific primers: *cheY* up Fw (5′-CTG CAG TGA ATG TGA GCC TCG AAC TC-3′) and *cheY* down Rev (5′-GGA TCC GCA TTG AGA AGA TCC CTG TC-3′). It cloned into the pGEM-T Easy vector (Promega, WI, United States). To delete a 381-bp DNA fragment of *cheY*, the plasmid was amplified by inverse PCR using specific primers: Inv Fw (5′-TTA GGG CCC CAA AAT TGC CTC CAC TGA AT-3′) and Inv Rev (5′-GCC GTG CAC TAA ACC TCG TTT GAA GAT TA-3′), treated with *DpnI* to digest methylated parental plasmids, and self-ligated. The plasmid was digested with *Apa*I and *Apa*LI and then cloned into the suicide vector pYAK1.

The generated plasmids, pYAK1-*pomA*KO and pYAK1-*cheY*KO, were introduced into *Escherichia coli* BW19795. The transformants were combined with *V. vulnificus* on a nitrocellulose Hybond C membrane (GE Healthcare, Tokyo, Japan) for conjugation, placed onto an M9 agar plate, and incubated at 25°C ([@B15]; [@B10]; [@B59]). The bacterial suspension was plated onto TCBS agar containing 10 μg/ml chloramphenicol and incubated overnight at 37°C for selection ([@B58]). *V. vulnificus* CMCP6, retaining pYAK1- *pomA*KO and pYAK1-*cheY*KO, were cultured in LB broth containing 20% sucrose. The resulting strain due to *sacB*-assisted allelic exchange was named Δ*pomA* and Δ*cheY* ([@B47]; [@B34]).

Complementation of Δ*cheY*
--------------------------

The *cheY* gene was amplified using specific primers: *cheY* Fw (5′-GGA TCC TTG AAT AAA AAC ATG AAG ATC CTT ATT-3′) and *cheY* Rev (5′-CTC GAG TTA TAA ACG TTC AAA AAT TTT ATC TAG-3′). It cloned into pACYC184 by Infusion cloning reactions (Clontech, TaKaRa, Shiga, Japan). The complementing plasmid pACYC184-*cheY* was introduced into *V. vulnificus* via electroporation. After inoculation onto LB plate containing 10 μg/ml chloramphenicol and incubation overnight at 37°C for selection, the strain retaining the plasmid was named p*cheY*. The *cheY* gene could be expressed from the *cat* promotor on this plasmid ([@B77]).

Swarming Assay
--------------

*Vibrio vulnificus* CMCP6 parent strain (WT) were grown in LB medium, and each signature-tagged transposon insertion mutants were grown in LB medium containing 100 μg/ml of kanamycin at 37°C. Overnight cultures (100 μl) were inoculated into 2 ml of fresh medium and incubated for 2 h. Log-phase bacteria were inoculated onto LB plates containing 0.3% agar and incubated for 12 h at 37°C.

Capsule Assay
-------------

WT and E4 were grown in LB medium, and each signature-tagged transposon insertion mutants were grown in LB medium containing 100 μg/ml of kanamycin at 37°C. Overnight cultures (5 μl) were inoculated onto LB plate and incubated for 12 h at 37°C. The opacity of the colonies was examined.

Bacterial Proliferation Analysis in Muscle Tissue
-------------------------------------------------

WT andΔ*cheY* were grown in LB medium containing 50 mg/ml of rifampicin, and p*cheY* was grown in LB medium containing 50 mg/ml of rifampicin and 10 μg/ml chloramphenicol with agitation (163 rpm) at 37°C. Overnight cultures (100 μl) were inoculated into 2 ml of fresh medium and incubated for 2 h. Bacteria were harvested, washed with PBS (pH 7.2) containing 0.1% gelatin, and resuspended in fresh medium. Then, 10^6^ CFU/mouse were subcutaneously inoculated into right caudal thighs. Infected mice were sacrificed at 6 h post-infection. The collected muscular tissue was suspended in PBS containing 0.1% gelatin, homogenized for 5 s with a lab mixer IKA EUROSTAR digital (IKA Werke, Germany; 1,300 rpm), and centrifuged at 800 rpm for 5 min. The supernatant was plated at 10-fold serial dilutions in duplicate on LB agar containing 50 μg/ml rifampicin and incubated for 12 h at 37°C. *V. vulnificus* colonies were counted, and the number of CFU/g of muscle tissue was determined as a bacterial burden in muscle tissue.

Results
=======

Screening of Mutants in the Wound Infection Model and Identification of Crucial *V. vulnificus* Genes for Proliferation in the Healthy Hosts
--------------------------------------------------------------------------------------------------------------------------------------------

A total of 86 sets of libraries consisting of 5418 independent transposon insertion mutants were examined by comparing the presence of each tagged mutant between the input pool and the output pool samples (Figure [1](#F1){ref-type="fig"}). Overall, 71 mutants produced weak signals or lacked any signals upon comparing the hybridized output pool with the input pool (Figure [1](#F1){ref-type="fig"}), and were selected as attenuated mutant strains in which a virulence gene was disrupted by the insertion of a transposon. Although 11 out of 71 clones (5 genes: VV1_0217, VV1_0400, VV1_0778, VV1_2145, and VV2_0843) were detected twice or three times in this study, the transposon insertion sites of all attenuated strains were different even within the same gene. Of the identified genes, 82% were located in chromosome I and 18% were in chromosome II (Figure [2A](#F2){ref-type="fig"}). The encoded proteins of transposon-inserted genes were broadly grouped based on the KEGG pathway database^[3](#fn03){ref-type="fn"}^ and their putative function: cellular component, metabolism, regulation, and uncertain function proteins (Figure [2B](#F2){ref-type="fig"}).

![Broad grouping of genes detected by STM screening **(A,B)** Genes detected by STM were broadly grouped. Pie charts showing their chromosomal localization **(A)** and their predicted function **(B)**.](fmicb-10-00123-g002){#F2}

Flagellum and Pili
------------------

Genes that express putative cellular component proteins were found to be involved in the construction of the flagellum, membranes, phage, and pili (Figure [3A](#F3){ref-type="fig"}). *V. vulnificus* has a polar single flagellum. Flagellar-based motility is involved in swimming in liquid medium and swarming on surfaces ([@B53]). A list of detected genes involved in the flagellum and its predicted function are summarized in Table [1](#T1){ref-type="table"}. The detected genes were involved in the assembly or components of the flagellar MS-ring (*fliF*), C-ring (*fliM*), hook (*flgK*), filament cap (*fliD*), and motors (*pomA* and *motX*) ([@B82]; [@B61]; [@B14]; [@B17]). Genes for a component of the flagellar Type III secretion system (*fliH*, *fliI*, and *flhB*) and flagellar hook-length control (*fliK*) were responsible for flagellin export ([@B48]). All strains carrying a disruption of any gene for flagellar proteins exhibited a defect in swarming motility (Table [1](#T1){ref-type="table"} and Figure [4](#F4){ref-type="fig"}). Genes for FimT, FimV, and CpaE-like proteins are involved in the synthesis of Type IV pili (Tfp) (Table [1](#T1){ref-type="table"}). Our findings indicate that the flagellum and pili of *V. vulnificus* are essential for the wound infection.

![Detailed classification of the identified genes **(A--C)** Pie charts showing details of the predicted functions of encoded proteins of the genes detected by STM: cellar component **(A)**, metabolism **(B)**, and regulation **(C)**.](fmicb-10-00123-g003){#F3}

###### 

Genes involved in *V. vulnificus* wound infection.

  Gene tag   Name     Gene product                              *In vitro* phenotype     Predicted function in the wound infection
  ---------- -------- ----------------------------------------- ------------------------ --------------------------------------------------------------------------
  VV1_0217   *flgK*   Flagellar hook filament junction          • Non-motile             • Spread in soft-tissues
  VV1_0312   *pomA*   Flagellar Na+ motor (torque generation)   • Non-motile             • Transition to the systemic
  VV1_1300   *motX*   Flagellar Na+ motor component             • Non-motile             circulation
  VV1_1928   *fliD*   Flagellar filament cap                    • Non-motile             
  VV1_1935   *fliF*   Flagellar MS-ring                         • Non-motile             
  VV1_1937   *fliH*   Fla export; negative regulator of FliI    • Non-motile             
  VV1_1938   *fliI*   Fla export ATPase                         • Non-motile             
  VV1_1940   *fliK*   Flagellar hook-length control             • Non-motile             
  VV1_1942   *fliM*   Flagellar motor switch component/C-ring   • Non-motile             
  VV1_1948   *flhB*   Fla export                                • Non-motile             
  VV1_1953   *cheY*   Transmits chemoreceptor signals           • Smooth bias swimming   
  VV1_1955   *cheA*   Sensor kinase                             • Smooth bias swimming   
  VV1_1958   *cheW*   Purine-binding chemotaxis protein         • Non-motile             
                                                                                         
  VV1_0352   *fimT*   Tfp pilus assembly                                                 • Adhesion to cells
                                                                                         • Biofilm formation
                                                                                         
                                                                                         
  VV1_1991   *fimV*   ATPase AAA pilus assembly                                          
  VV1_2333            Pilus assembly (CpaE-like protein)                                 
                                                                                         
  VV1_0578   *murG*   Glycosyltransferase                                                • Maintenance of bacterial cell morphology
                                                                                         
  VV1_0778            Glycosyltransferase                       • Translucent colony     • Resistance to immune cells in soft tissue and the systemic circulation
  VV1_1426   *wza*    Lipid A core-O-antigen ligase             • Non-motile             • Induction of inflammatory cytokines
  VV1_0786   *gpsK*   Polysaccharide export                     • Translucent colony     
  VV1_1667            Glucosamine kinase                                                 
                                                                                         
  VV2_0843   *vuuA*   Ferric vulnibactin receptor                                        • Siderophore-mediated iron acquisition
  VV2_1016   *iutA*   Aerobactin siderophore receptor                                    
                                                                                         
  VV1_2145   *mukB*   Chromosome partition                                               • Chromosome partition and cell division.
  VV1_2245            DNA polymerase III subunit epsilon                                 
  VV2_0122            DNA helicase IV                                                    

![Swarming motility of WT and the mutants lacked genes involved in the flagellum.](fmicb-10-00123-g004){#F4}

Carbohydrate and Iron Metabolism
--------------------------------

The genes involved in metabolism included those responsible for the utilization of carbohydrate and iron (Figure [3B](#F3){ref-type="fig"}). Glycosyltransferase gene of N-acetylglucosamine (GlcNAc) metabolism was primarily detected in carbohydrate metabolism (Figure [3B](#F3){ref-type="fig"} and Table [1](#T1){ref-type="table"}). The metabolism and biosynthesis of GlcNAc are required for the bacterial cell wall, peptidoglycans, and outer membrane; i.e., lipopolysaccharides (LPS) ([@B41]; [@B71]; [@B36]). In addition, strains carrying a disruption of glycosyltransferase (VV1_0778) gene exhibited translucent colony (Figure [5](#F5){ref-type="fig"}), meaning reduced capsular polysaccharides (CPS) expression ([@B36]).

![Colony morphology of WT, environmental strain E4, and VV1_0778::Tn.](fmicb-10-00123-g005){#F5}

In iron metabolism, the genes for VuuA and IutA were detected in this study (Table [1](#T1){ref-type="table"} and Figure [3B](#F3){ref-type="fig"}). These are outer membrane receptors of iron chelators (siderophores) that is a high affinity protein against iron, which is necessary for bacterial proliferation ([@B75]; [@B69]; [@B76]; [@B29]). Thus, these findings indicate that *V. vulnificus* requires an iron acquisition system for their proliferation in healthy hosts.

Regulation of Chemotaxis and Cell Division
------------------------------------------

Mutant strains of chromosome partition protein MukB, DNA helicase, and DNA polymerase showed equivalent proliferation as the parent strain *in vitro* but were detected by the STM method (Table [1](#T1){ref-type="table"}). It indicates the existence of regulators of chromosomal replication functioning only *in vivo*. Two transposon insertion mutants that lacked chromosome partition protein MukB were detected in the STM. Each mutant was expressed 918 or 1269 amino acid residues of MukB, which is composed of 1484 amino acid residues. Both *mukB*::Tn mutants did not exhibit a growth defect *in vitro*. We have attempted to construct an in-frame deletion mutant of MukB to verify the phenotypes of *mukB*::Tn, but it could not be obtained. Thus, our results suggest that MukB is essential for the survival of *V. vulnificus* and the C-terminal domain of MukB likely plays key roles *in vivo*.

In order to sense and respond to various environmental conditions, the two-component system, which regulates the direction of flagellar rotation based on sensing of chemoattractants or chemorepellents in bacterial chemotaxis ([@B7]), along with regulation of cell division are essential in bacteria (Figure [3C](#F3){ref-type="fig"}). The two-component system consists of sensor kinase and response regulators and accomplishes signal transduction via their phosphorylation ([@B21]; [@B74]). In the present study, a histidine kinase (CheA), a response regulator (CheY), and an adapter protein (CheW) for chemoreceptors and the histidine kinase in *V. vulnificus* chemotaxis were detected (Table [1](#T1){ref-type="table"}; [@B84]). To determine a responsible gene for chemotaxis and whether the chemotaxis is essential for proliferation at the site of the wound infection, we inoculated WT, Δ*cheY*, or p*cheY* into the murine subcutaneous tissue and then analyzed bacterial burdens in the muscle tissue beneath the inoculation site at 6 h post-infection. Average CFU values in WT-infected mice was 5.97 × 10^6^ CFU/g. In contrast, the average CFU in the Δ*cheY*-infected mice was significantly lower, 3.59 × 10^4^ CFU/g (Figure [6](#F6){ref-type="fig"}). The Δ*cheY* mutant exhibits approximately 15-fold reduced bacterial burden (*p* = 0.0043) in the tissue compared with WT, and the bacterial burden was recovered by complementation with *cheY* (Figure [6](#F6){ref-type="fig"}). These results demonstrate that chemotaxis, as well as flagellum construction, were essential for *V. vulnificus* proliferation at the local site of the wound infection.

![Bacterial burdens calculated as CFU/g in the muscle tissue of mice (*n* = 6/group) s.c.-inoculated with WT, Δ*cheY*, and p*cheY* at 6 h post-infection. Error bars indicate SEM. ^∗^*P* \< 0.05, ^∗∗^*P* \< 0.01; Mann-Whitney *U*-test.](fmicb-10-00123-g006){#F6}

Discussion
==========

Chromosomal Location of Functional Genes
----------------------------------------

We classified and selected 71 clones from among 5418 independent transposon insertion mutants. Although genes involved in the known virulence factors of *V. vulnificus*, such as MARTX, VVH, VvpE, the and iron acquisition system, are located on chromosome II ([@B49]; [@B24]; [@B8]; [@B25]), our detected genes mainly were localized on chromosome I. These findings indicate that the genes encoding essential functions for proliferation and spreading in healthy hosts during wound infection are preferentially situated on chromosome I.

Adhesion and Biofilm Formation
------------------------------

Type IV pili are known to play a role in cell adhesion, twitching motility, and the uptake of foreign genes ([@B55]; [@B6]). Studies on *Pseudomonas aeruginosa* indicate that the FimT, FimV, and CpaE-like protein are involved in Tfp assembly ([@B46]). Tfp of *P. aeruginosa* is essential for twitching motility, however, that of *V. vulnificus* is expected to be functionally distinct ([@B25]; [@B6]). Pili contribute to pathogenicity via biofilm formation and adhesion to epithelial cells in *V. vulnificus* infection ([@B54]; [@B55]; [@B25]). [@B16] showed that clinically isolated strains of *V. vulnificus*, especially those isolated from wound infection sites, presented higher numbers of pilus fibers per cell than environmentally isolated strains. [@B55] further reported that pili-deficient mutants of *V. vulnificus* exhibited decreased adhesion to cells, biofilm formation, and lethality in iron dextran-treated mice. Together with these data, the results of the present study first showed the essential genes for and importance of pili in the wound infection, suggesting the possibility that Tfp of *V. vulnificus* may be involved in the adherence to cells and biofilm formation in soft tissues at the wound infection site (Figure [7A](#F7){ref-type="fig"}).

![STM screening reveals the essential factors whereby *V. vulnificus* invades, spreads, proliferates, and causes wound infection. **(A)** *V. vulnificus* adheres to cells located at the local wound infection site via the pilus. Biofilm formation and CPS contribute to resistance against immune cells. **(B)** *V. vulnificus* spreads in soft-tissues by flagellar based motility based on chemotaxis. **(C)** Two different sizes of chromosomes enable rapid chromosome replication leading to rapid cell division and proliferation. Iron, which is an essential element in bacterial metabolic and informational cellular pathways, is acquired via a siderophore-mediated system. **(D)** CPS and LPS induce inflammation-associated cytokines leading to septic shock.](fmicb-10-00123-g007){#F7}

Bacterial Spreading in Soft-Tissues and Transition to the Systemic Circulation
------------------------------------------------------------------------------

The flagellum is structurally composed of the basal body, hook, and filament ([@B61]; [@B20]; [@B14]; [@B17]; [@B70]). The basal body serves as a rotation axis and consists of the MS-ring, C-ring, PL-ring, and rod. The C-ring of the basal body interacts with the motor protein and functions as a rotor ([@B82]). The hook transmits the torque generated in the basal body to the filament. The basal body rod, hook, and filament are transported through the central channel of the flagellum by the flagellar Type III secretion system that exists in the cytoplasm ([@B48]; [@B57]). The filament is made of polymerized flagellin proteins and forms a spiral shape. It has been reported that mutants disrupting flagellar hook-basal body, flagellin, and controlling flagellum expression exhibited significant decreases in invasion ability from the intestine into the systemic circulation, as well as in lethality during intragastric infection of suckling mice ([@B32], [@B31]; [@B13]). In addition, we reported that immunization with flagellin can prevent *V. vulnificus* proliferation in a local wound infection site ([@B81]). These findings show that the flagellum is required for proliferation both in the intestine and in soft-tissues at the local wound infection site and for invasion of the systemic circulation (Figure [7B](#F7){ref-type="fig"}).

Bacteria change swimming direction by tumbling consequent to switching the direction of flagellar rotation from counterclockwise to clockwise ([@B22]; [@B84]) and move toward a favorable environment through the proper control of flagellar rotation based on chemotaxis, which is controlled by the two-component system ([@B7]). Methyl-accepting chemosensory proteins (MCPs) sense chemical gradients of the surrounding environments, bind chemoattractants or chemorepellents, and transmit chemotactic signals to CheW interacting with CheA ([@B84]). CheA is involved in the activation (phosphorylation) of CheY. When the activated CheY binds to the switch protein FliM, the direction of flagellar rotation is altered from counterclockwise to clockwise ([@B11]; [@B4]). Our observation that CheY and CheA mutants swim straight is a consequence of counterclockwise-biased flagellar rotation (smooth biased) (Table [1](#T1){ref-type="table"}). They will swim straight *in vivo* as well as *in vitro* and may not able to spread in soft tissues which have complex and intricate structures. It must have resulted in a non-sufficient proliferation by Δ*cheY* at the local wound infection site and not be detected from spleen as a STM output (Figure [6](#F6){ref-type="fig"}). Together, our findings revealed that in addition to the complete flagellum, flagellar rotation control based on chemotaxis is essential for *V. vulnificus* to spread in soft tissue and proliferate at the site of wound infection. Notably, the chemotaxis of *V. vulnificus* associated with tissue tropism or invasion of the systemic circulation has not previously been investigated. However, although approximately 40 genes encoding MCPs exist on *V. vulnificus* chromosomes, these were not detected in the present study. Identification of the chemoattractants underlying bacterial spread in soft tissue and transition to the systemic circulation will therefore likely be helpful to prevent the development of sepsis.

Rapid Proliferation
-------------------

Several pathogens, such as *Salmonella enterica serovar* Typhi, *Vibrio cholerae*, and *E. coli*, secrete siderophore during intestinal tract infection ([@B76]). It is thought that *V. vulnificus* also secretes siderophore in primary septicemia through the digestion of raw seafood ([@B66]; [@B38]; [@B25]; [@B68]; [@B52]). Notably, patients with primary septicemia have underlying diseases such as liver cirrhosis, hemochromatosis, or alcoholism, which predispose to iron overload. In fact, the elevation of serum iron levels in hosts is highly associated with *V. vulnificus* infection ([@B3]; [@B39]; [@B2]). Unlike in such patients, iron is limited in a healthy host and usually stored as heme in erythrocytes (hemoglobin) and muscle (myoglobin), or ferritin in hepatocytes. Extracellular iron is bound to transferrin in the serum and lactoferrin in secretions. In addition, [@B2] reported that the hepcidin secreted by hepatocytes suppresses serum iron levels during *V. vulnificus* infection. Unlike in septicemia, in soft-tissue infection, one a single study has reported that *P. aeruginosa* secretes siderophore, in a murine model of surgical site infection ([@B30]). These observations indicate that it would be difficult for pathogens to acquire iron from the iron regulatory system in a healthy host. Our result is strongly suggested that siderophore secretion and siderophore receptors (ferric vulnibactin receptor and aerobactin siderophore receptor) are essential to acquire iron for the proliferation of *V. vulnificus* during wound infection in healthy hosts (Figure [7C](#F7){ref-type="fig"}). It is consistent with the previous report that the expression of these receptors in *V. vulnificus* is enhanced under *in vitro* iron-restricted conditions ([@B29]).

*Vibrionaceae* bacteria such as *V. vulnificus*, *V. cholerae*, and *Vibrio parahaemolyticus* have two differently sized chromosomes that each contain an origin for replication ([@B63]; [@B8]; [@B62]; [@B72]). This characteristic enables rapid chromosome replication, cell division, and proliferation and is likely essential for the proliferation of *V. vulnificus* in the wound infection. In particular, several studies on *E. coli* have shown that MukB acts as a homodimer, condenses DNA, and facilitates chromosome segregation ([@B50]).

We also detected a *murG* mutant by STM. In *P. aeruginosa* and *E. coli*, MurG plays a key role in the biosynthesis of the peptidoglycan layer to form a glycosidic bond between N-acetylmuramyl pentapeptide and GlcNAc for bacterial cell walls ([@B44]; [@B5]; [@B12]; [@B64]). The bacterial cell wall contributes to cellular integrity, determination of shape, and adaptation to the surrounding environment, allowing cell expansion during growth and cell separation after cell division. Accordingly, mutation in the cell wall composition affected not only morphology of the bacterial cells but also the rapid cell division (Figure [7C](#F7){ref-type="fig"}).

Immune Evasion and Pathogenesis
-------------------------------

[@B56] and [@B65] showed a mutant strain of *wbpP* gene encoding GlcNAc C4 epimerase is CPS-deficient. Thus, GlcNAc metabolism is essential for the synthesis of CPS. CPS is considered essential for *in vivo* proliferation, as clinically isolated strains typically produce CPS unlike environmentally isolated strains ([@B83]; [@B67]). It has been reported that CPS of *V. vulnificus* is essential for the evasion of phagocytosis by macrophages as well as for serum resistance ([@B79]; [@B78]). In addition, capsular (opaque) strains are more invasive than non-capsular (translucent) strain in guinea pig subcutaneous tissue ([@B83]; Figure [7A](#F7){ref-type="fig"}). Synthesized CPS is transported through a channel in the bacterial outer membrane formed by the lipoprotein Wza, of which deficient mutants showed translucent colonies, increased serum sensitivity, and reduced lethality in mice ([@B79]). In turn, LPS constitutes a polysaccharide side chain that comprises lipid A, core oligosaccharide, and O antigen. The lipid A core-O-antigen ligase that was detected in the present study functions to bind O-antigen polysaccharide to the lipid A-core oligosaccharide ([@B1]). It was reported that sialic acid modification of LPS is required for *V. vulnificus* to proliferate in the systemic circulation ([@B42]). However, Wza and the sialic acid modification of LPS are also involve in flagellar assembly ([@B42]). These results complicate the interpretation of which factor(s) among CPS, LPS, or the flagellum is the most important for each function. However, although further study is required to clarify this issue, the importance of CPS, LPS, and the flagellum was suggested by the detection of mutants that specifically disrupted each factor in our STM (Table [1](#T1){ref-type="table"}). In addition, CPS and LPS of *V. vulnificus* serve as inducers of tumor necrosis factor-alpha ([@B60]), which has the potential to cause endotoxic shock. Together, our findings suggest that LPS and CPS of *V. vulnificus* contribute to the initial establishment and fatal outcomes in both primary septicemia and wound infection (Figures [7A,D](#F7){ref-type="fig"}).

Conclusion
==========

Our findings demonstrate that the pathogenicity of *V. vulnificus* during wound infection highly depends on its characteristics; motility, iron-acquisition, CPS, LPS, and two circular chromosomes. In addition, we identified novel factor: chemotaxis, which likely enables *V. vulnificus* to spread toward a suitable environment, rapidly proliferate especially at the local infection site, and aggravate wound infection within a short period. These factors comprise attractive potential candidates for the development of antibiotics or vaccines to control infection.

Author Contributions
====================

KY and TKas contributed to the conception and design of the study. KY performed the majority of the experiments and analyzed the data. MM and TKad assisted STM. KY wrote the manuscript. SU analyzed and supervised this study. All authors contributed to manuscript revision and read and approved the submitted version.

Conflict of Interest Statement
==============================

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

**Funding.** This work was partly supported by the Japan Society for the Promotion of Science KAKENHI Grant Numbers 26450411 and 18H02350, and by the Grant for Joint Research Project of the Research Institute for Microbial Diseases, the University of Osaka. The funder had no role in study design, data collection, and interpretation, or the decision to submit the work for publication.

<http://www.jgi.doe.gov/programs/GEBA/index.html>

<https://www.genome.jp/kegg>

<https://www.genome.jp/kegg/pathway.html>

[^1]: Edited by: Rustam Aminov, University of Aberdeen, United Kingdom

[^2]: Reviewed by: Iddya Karunasagar, Nitte University, India; Christopher Staley, University of Minnesota Twin Cities, United States; Yonghong Xiao, Zhejiang University, China

[^3]: This article was submitted to Infectious Diseases, a section of the journal Frontiers in Microbiology
